| abstract |
This invention provides compounds of Formula (I) having structure (I), wherein R1, R2 are both hydrogen or form a bond, or are each, independently, alkyl of 1-6 carbon atoms or aryl of 6-12 carbon atoms; m = 0-10; n = 1-3; and p = 0-10; with the proviso that m + p is less than or equal to 15; or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. |